CD276 and nonpapillary renal cell carcinoma: Notably, Inamura et al. found that only 37 out of 252 ccRCC cases (15%) demonstrated high CD276 expression within tumor cells; however, 137 samples (54%) displayed elevated expression levels in the tumor vasculature.